NCI-H1650 In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
CAT#: ITS-0123-YF1143
Target Cell Organism: Human
Target Cell Alternative Name: H-1650; H1650
Target Cell Name: NCI-H1650
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide NCI-H1650-based In Vitro Protein Expression Analysis Assay (Immunoprecipitation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H1650
Target Cell Organism
Human
Target Cell Background
NCI-H1650 [H-1650, H1650] is a cell line exhibiting epithelial morphology that was isolated in 1987 from the lung tissue of a 27-year-old, male smoker with stage 3B, bronchoalveolar carcinoma. Use these cells for your immuno-oncology and lung cancer research.
Target Cell Alternative Name
H-1650; H1650
Related Diseases
Lung Cancer
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.